TABLE 2.
Baseline characteristics of 90 CRC patients and healthy controls.
| Characteristics | Patients | Control | p value |
|---|---|---|---|
| Gender | — | — | — |
| Male | 55 | 12 | 0.17 a |
| Female | 35 | 8 | — |
| Age | — | — | 0.08 a |
| <60 | 50 | 11 | — |
| ≥60 | 40 | 9 | — |
| Degree of differentiation | — | — | — |
| Poor | 25 | — | — |
| Well | 65 | — | — |
| Tumor diameter(cm) | — | — | — |
| <5 | 54 | — | — |
| ≥5 | 36 | — | — |
| T stage | — | — | — |
| Tis-T2 | 11 | — | — |
| T3-T4 | 79 | — | — |
| N stage | — | — | — |
| Absent | 22 | — | — |
| Present | 68 | — | — |
| M stage | — | — | |
| M0 | 41 | — | — |
| M1 | 49 | — | — |
| Clinical stage | — | — | — |
| Early stage (I-II) | 2 | — | — |
| Advanced stage (III-IV) | 70 | — | — |
| CEA (ng/L) | — | — | — |
| <5 | 42 | — | — |
| ≥5 | 48 | — | — |
a
Note: : independent-samples t test.